Global Pharmaceuticals & Biotech Nano Cap Stocks

Synbio Tech

Market Cap: NT$1.6b

Manufactures and sells human healthcare products and probiotics for animals.

Mereo BioPharma Group

Market Cap: US$48.3m

A biopharmaceutical company, develops and commercializes therapeutics for the treatment of rare diseases in the United Kingdom and the United States.

Vext Science

Market Cap: CA$66.9m

Through its subsidiaries, engages in integrated cannabis operations in the United States.

Decibel Cannabis

Market Cap: CA$66.4m

An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.

Kidswell Bio

Market Cap: JP¥7.5b

Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.

Sinsin Pharmaceutical

Market Cap: ₩67.2b

Manufactures and sells pharmaceutical products in South Korea.

Cantargia

Market Cap: SEK 449.5m

A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.

May & Baker Nigeria

Market Cap: ₦63.8b

May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.

Covalon Technologies

Market Cap: CA$65.3m

Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally.

Norda

Market Cap: NOK 443.4m

A biotechnology company, engages in the cancer diagnostic activities.

Austar Lifesciences

Market Cap: HK$361.4m

An investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally.

Planet 13 Holdings

Market Cap: CA$63.7m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

Uni-Bio Science Group

Market Cap: HK$352.3m

An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in Hong Kong, and People’s Republic of China.

Grace Therapeutics

Market Cap: US$44.2m

Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.

MindMaze Therapeutics Holding

Market Cap: CHF 34.8m

Operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally.

Botanix Pharmaceuticals

Market Cap: AU$60.2m

Operates as a commercial dermatology company in Australia and the United States.

Navamedic

Market Cap: NOK 402.9m

A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.

Wai Yuen Tong Medicine Holdings

Market Cap: HK$312.0m

An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.

P&K Skin Research Center

Market Cap: ₩56.3b

Engages in the evaluation and research of dermatological products in South Korea.

WDB coco

Market Cap: JP¥6.2b

Provides outsourcing and support services for pharmaceutical and medical device development in Japan.

RP Bio

Market Cap: ₩54.7b

A bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally.

Infinium Pharmachem

Market Cap: ₹3.6b

Engages in the manufacture and supply of iodine, iodine derivatives, and active pharmaceutical ingredients (APIs) in India and internationally.

Rhone Ma Holdings Berhad

Market Cap: RM 150.9m

An investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia.

Radiopharm Theranostics

Market Cap: AU$52.1m

A clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs.

Medical Developments International

Market Cap: AU$51.8m

Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.

SkinBioTherapeutics

Market Cap: UK£26.6m

A life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally.

Beit Jala Pharmaceutical

Market Cap: د.أ25.3m

Engages in the manufacture and sale of pharmaceutical products in the Palestinian Authority.

Sprint Bioscience

Market Cap: SEK 340.8m

A pharmaceutical company, engages in the development of drug candidates to treat cancer in Sweden.

CCME Global

Market Cap: ₹3.1b

Does not have significant operations.

Winston Medical Supply

Market Cap: NT$1.1b

Develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally.

BioXcel Therapeutics

Market Cap: US$32.7m

Together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States.

Vidipha Central Pharmaceutical

Market Cap: ₫861.3b

Produces and sells pharmaceutical products in Vietnam.

Prince Pharmaceutical

Market Cap: NT$1.0b

Manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally.

Dyadic International

Market Cap: US$32.1m

A biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States.

Seoulin BioscienceLtd

Market Cap: ₩41.8b

A bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea.

Bioqual

Market Cap: US$29.1m

Provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.